Live from the NIH registry
Studies recruiting near Milwaukee right now
Top 25 of 693 recruiting studies, sorted by proximity — each links to its official registry page
External UES Band (Shaker Pressure Band) and GERD
Gastroesophageal Reflux
N/A
Interventional 350 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 12 participants sought
Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Study of EV for Recurrent Endometrial Carcinoma
Endometrial Cancer
Phase 2
Interventional 12 participants sought
Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: William Bradley
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
Diabetes Mellitus, Type 2
Phase 2
Interventional 100 participants sought
Center for Advancing Population Science, Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Synairgen Research Ltd.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina & Vitreous Consultants of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
GpCRC Pediatric Gastroparesis Registry 2
Gastroparesis, Gastroparesis-like Syndrome
N/A
Observational 216 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
Hematologic Tests
N/A
Interventional 425 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Abbott Point of Care
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Children's Hospital of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: AstraZeneca
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
HIV Infections
N/A
Interventional 63,000 participants sought
Children's Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: AstraZeneca
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Leukemia, Acute Myeloid Leukemia in Remission
N/A
Interventional 40 participants sought
Children's Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Phase 1
Interventional 40 participants sought
Children's Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Children's Hospital of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 3
Interventional 582 participants sought
Research Site — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Incyte Corporation
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Venous Thromboses, Venous Disease
N/A
Interventional 165 participants sought
Medical College of Wisconsin - Froedtert Hospital — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: W.L.Gore & Associates
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 220 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Regeneron Pharmaceuticals
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Ascension Medical Group Southeast Wisconsin - Mayfair Road — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Phase 3
Interventional 558 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: BioNTech SE